Stereotactic body radiotherapy for extra-cranial oligoprogressive or oligorecurrent small-cell lung cancer

Antonin Levy,Jonathan Khalifa,Etienne Martin,Angela Botticella,Clément Quevrin,Pernelle Lavaud,Mihaela Aldea,Benjamin Besse,David Planchard,Fabrice Barlesi, Eric Deutsch,Carole Massabeau,Jérôme Doyen,Cécile Le Péchoux

Clinical and Translational Radiation Oncology（2023）

引用 1|浏览14

暂无评分

摘要

•SBRT fore rare oligoprogressive (70%)/oligorecurrent SCLC.•The median LC/DR/OS were NR, 4.5 and 17.2 months, respectively.•Initial LS associated with decreased post-SBRT OS and DR.

查看译文

关键词

stereotactic body radiotherapy,small-cell small-cell lung cancer,lung cancer,extra-cranial

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要